Research published online last week in Nature Communications suggests that some of the cell lines most frequently used to study high-grade serous ovarian cancer (HGSOC) may not be the best. OCRF grantee and SAC member Douglas Levine, MD was one of the authors of the paper. Cell lines derived from tumor tissue are the most … Continued
In an article published last week in The Lancet, an international group of investigators examined whether ovarian cancer tumors’ expression of the progesterone receptor (PR) and estrogen receptor (ER) was associated with survival in various subtypes of ovarian cancer. To date, few biomarkers of ovarian cancer prognosis have been established. The study, which included 2,933 women, … Continued
“November 4, 1999 was one of those perfect autumn days in New York when it seems as though nothing could go wrong. But it did for me. That was the day I was diagnosed with ovarian cancer and the world as I knew it would never be the same,” says Valerie. “No one could have … Continued
Gynecologic Cancer Patients to Receive New Support in Tampa, Fla. and in Stanford, Calif. WEST CHESTER, Pa (Thursday, July 11, 2013) —Ovarian Cancer Research Fund (OCRF) and QVC today announced two new Woman to Woman grant recipients, Moffitt Cancer Center in Tampa, Fla. and Stanford Women’s Cancer Center in Stanford, Calif. QVC united with OCRF … Continued
Experts agree: “If you or a close relative has been diagnosed with ovarian cancer, speak to your doctor about getting genetic counseling.” In the wake of Angelina Jolie’s announcement that she carries a genetic mutation linked to breast and ovarian cancers, thousands of women are wondering whether they are at risk. To address their concerns, … Continued
Women with a family history of breast cancer but no BRCA1/2 mutation were found to be at average risk for developing ovarian cancer. The prospective study of 8005 women from a breast cancer family history clinic found that women with a BRCA2 mutation had a 17-times higher risk of developing ovarian cancer than average, and … Continued
With 5 states to go, the ovarian cancer survivor is in the home stretch of her 50-state, $100,000 campaign.
Deb Stevens was inspired to start the Feel Teal Club “after the loss of my dear mother to the disease,” she recalls. Deb published her first book and dedicated the proceeds to cancer research. Shortly after, she says, “I joined up with an Australian based ovarian cancer network, hosting events to raise the level of … Continued
In an interview, 3-time grantee Dr. Zhang discusses his research and what it means to receive an award from OCRF.
We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new studies on or related to ovarian cancer were presented at this year’s ASCO meeting. Click here to read a summary of ovarian cancer research from … Continued
In a unanimous ruling issued June 13, 2013, the US Supreme Court ruled that private companies do not have the right to patent human genes. In Association for Molecular Pathology et al. v. Myriad Genetics, the court considered the validity of patents held by the Utah-based company Myriad Genetics for the BRCA1 and BRCA2 genes, which … Continued
Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent the ovarian patient community. Other diseases, including cancer, brain and heart disease are represented as well. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
